site stats

Firebrick pharma stock

WebFeb 5, 2024 · FIREBRICK PHARMA LIMITED. Delayed Australian Stock Exchange - 10:32:34 2024-02-05 pm EST. Firebrick Pharma Identifies New Indication for Nasal Spray Product. Australian Shares Erase Early Gains as Profit-Taking Weighs Down Financial Counters. Firebrick Pharma Identifies New Indication for Nasal Spray Product. WebAU$1.10m. Market Cap. AU$32.22m. FRE key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise …

Firebrick Pharma Ltd (FRE) Stock Price & News - Google Finance

WebFirebrick Pharma Limited. CHIA:FRE Stock Report. Mkt Cap: AU$32.2m. Add to watchlist. Company Overview; 1 Valuation; 2 Future Growth; 3 Past Performance; 4 Financial Health; 5 Dividend; 6 Management; 7 Ownership; Other Information; View Ownership. Firebrick Pharma Company Information. Firebrick Pharma Limited's employee growth, exchange ... WebFirebrick Pharma General Information. Description. Firebrick Pharma Ltd is an Australian pharmaceutical developer. It is engaged in the development and commercialisation of Nasodine, a broadspectrum anti-viral spray, designed to be an effective treatment and prevention of respiratory viral infections such as the common cold. bionic boots keahi seymour https://bdmi-ce.com

Firebrick Pharma - FRE Stock Forecast, Price & News

WebManufacturing. Pharmaceutical. Headquarters Regions Asia-Pacific (APAC), Australasia. Founded Date 2012. Operating Status Active. Legal Name FIREBRICK PHARMA LIMITED. Stock Symbol ASX:FRE. Company Type For Profit. Firebrick Pharma produces nasal spray that combats the viral source of the common cold. WebApr 6, 2024 · Forgot password ? Remember WebApr 6, 2024 · Firebrick Pharma Limited has completed an IPO in the amount of AUD 7 million. Firebrick Pharma Limited Announces Resume of Phase 3 Clinical Trial of … daily tribune mt pleasant tx

FRE Firebrick Pharma Stock Price - StockLight

Category:Stock News FIREBRICK PHARMA Stock Price Today

Tags:Firebrick pharma stock

Firebrick pharma stock

Firebrick Pharma - Crunchbase Company Profile & Funding

WebAll the latest Firebrick Pharma Limited (ASX:FRE) share price movements, news, expert commentary and investing advice from The Motley Fool Australia. WebMar 6, 2024 · How much money does Firebrick Pharma make? Firebrick Pharma (ASX:FRE) has a market capitalization of $0.00 and generates $1.10 million in revenue each year. The company earns $-5,390,000.00 in net income (profit) each year or A ($0.04) on an earnings per share basis.

Firebrick pharma stock

Did you know?

WebJan 28, 2024 · Virus-killing nasal spray developer, Firebrick Pharma Limited ... The company’s stock hit the market at 12:30 pm AEDT on Friday and quickly surged to a … WebJan 19, 2024 · Firebrick Pharma, which is developing a nasal spray for common cold, will list on the ASX after raising $7 million via an initial public offering. Firebrick Pharma …

WebFeb 3, 2024 · Of course Firebrick Pharma may not be the best stock to buy. So you may wish to see this free collection of companies boasting high return on equity, or this list of … WebFeb 3, 2024 · Of course Firebrick Pharma may not be the best stock to buy. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.

WebMay 24, 2024 · Firebrick Pharma Limited announced the appointment of Dr. Richard Treagus as a non-executive director on the Firebrick board of directors, with effect from 1 June 2024. Dr. Treagus was previously Commercial Director for Aspen Pharmacare in South Africa, responsible for sales and marketing of pharmacy and consumer products. Web: Get the latest Firebrick Pharma stock price and detailed information including news, historical charts and realtime prices.

WebFirebrick Pharma General Information. Description. Firebrick Pharma Ltd is an Australian pharmaceutical developer. It is engaged in the development and commercialisation of …

WebBut as Firebrick Pharma has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions. This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data. Show section. bionic boosterWebMar 6, 2024 · How much money does Firebrick Pharma make? Firebrick Pharma (ASX:FRE) has a market capitalization of $0.00 and generates $1.10 million in revenue … daily tribune news obituariesWebApr 9, 2024 · Summary of all time highs, changes and price drops for Firebrick Pharma; Historical stock prices; Current Share Price: AU$0.19: 52 Week High: AU$0.48: 52 … daily tribune newspaper bartow county gaWebFirebrick Pharma Pty Ltd is an Australian private company, founded in 2012 by two experienced pharmaceutical and biotech executives. dailytrick.xyzWebJul 20, 2024 · The Firebrick Pharma Ltd ( ASX: FRE) share price has been on form on Wednesday. At one stage today, the clinical-stage pharmaceutical developer’s shares were up 28% to 32 cents. The Firebrick ... daily tribune newspaper indiaWebApr 3, 2024 · This announcement has been authorised for release by the Board of Firebrick Pharma Limited.-ENDS-About Firebrick (FRE.ASX) Firebrick is a pharmaceutical company founded in 2012 to develop and commercialise a nasal spray treatment for the common cold based around the potential of povidone-iodine as a broad-spectrum … daily tribune without fear or favorWebFeb 17, 2024 · -- The US granted the patent application for Firebrick Pharma's Nasodine nasal spray for COVID-19, the Australian pharmaceutical company said Thursday. The patent covered the usage of any... April 8, 2024 ... Australian Stock Exchange; Firebrick Pharma Limited. News. Summary FRE AU0000197352. FIREBRICK PHARMA … daily tribune wisconsin rapids wi